Core Insights - Apollo Biowellness, Inc. has re-engaged GSS Capital for advisory services to assist in restructuring its balance sheet and converting all convertible and secured debt to comply with the Letter of Intent with Revive Regenerative, Inc. [1] - The company aims to raise $3,500,000 in capital for growth and expansion following the merger with Revive Regenerative, Inc. [1] Group 1 - GSS Capital has a history of successfully raising significant capital for the company and will assist in the restructuring phase while working with management to secure additional capital for the merged entity [3] - Apollo Biowellness, Inc. and its subsidiary, Evolutionary Biologics, Inc., focus on the discovery, development, and marketing of products in the field of Regenerative Medicine, particularly biologic-based products [4] - The company is currently marketing patent-pending natural stem cell mobilizing agents and a dual acting all-natural diet aid [4]

Core Viewpoint - Apollo Biowellness, Inc. has received approval to file on OTCIQ and is actively pursuing multiple strategic initiatives to enhance its product offerings and market presence [1][6]. Group 1: Product Development - The company is in final negotiations with a NASDAQ-listed Israeli Bio-Tech manufacturer for the co-development of a shelf-stable biologic cosmetic named Ceilo Skin Care, set to launch in Q4 2025 [3]. - Apollo plans to introduce a unique Pet and Veterinarian Biologic product utilizing exosomes and placental products, targeting issues like arthritis and inflammation in pets, with a launch before the end of Q3 2025 [5]. Group 2: Strategic Partnerships - The company is negotiating with a large aesthetic company specializing in Laser Energy Devices for a potential merger or business combination to create a combined therapy company [4]. Group 3: Financial Strategy - Apollo is working with its debt holders and convertible note holders to restructure, refinance, or convert most positions to a preferred class of equity, aligning with management's growth financing plans for the next 12 months [6]. Group 4: Company Overview - Apollo Biowellness, Inc. and its subsidiary, Evolutionary Biologics, Inc., focus on discovering, developing, and marketing biologic-based products aimed at improving human health, positioning itself as a leader in Regenerative Medicine [7][8].